Sigurd D. Süßmuth

Aggregation Substance Promotes Adherence, Phagocytosis, and Intracellular Survival of<i>Enterococcus faecalis</i>within Human Macrophages and Suppresses Respiratory Burst

Sigurd D. Süßmuth, Albrecht Muscholl‐Silberhorn, Reinhard Wirth et al. · Infection and Immunity · 2000 · 194 citations · Full text

Dysbiosis, Aggregation Substance, Microbial Pathogens +17

An exploratory double‐blind, randomized clinical trial with selisistat, a <scp>SirT1</scp> inhibitor, in patients with <scp>H</scp>untington's disease

Sigurd D. Süßmuth, Salman Haider, G. Bernhard Landwehrmeyer et al. · British Journal of Clinical Pharmacology · 2014 · 161 citations · Full text

Tau protein in cerebrospinal fluid (CSF): a blood–CSF barrier related evaluation in patients with various neurological diseases

Sigurd D. Süßmuth, Hansotto Reiber, Hayrettin Tumani · Neuroscience Letters · 2001 · 102 citations

Neurodegenerative Diseases, Neurobiology Of Disease, Medicine +11

Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum

Sigurd D. Süßmuth, Hayrettin Tumani, Daniel Ecker et al. · Neuroscience Letters · 2003 · 96 citations

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Proteinopathies +10

Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases

Sarah Jesse, Johannes Brettschneider, Sigurd D. Süßmuth et al. · Journal of Neurology · 2010 · 80 citations · Full text

Neurological Disorder, Neurochemical Biomarkers, Csf Routine Parameters +20